These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 207628)

  • 1. [Influence of clonazepam, an anticonvulsant benzodiazepine drug, on the rat brain monoamine containing neurons especially on dopaminergic neurons (author's transl)].
    Nakamura K; Shimokawa Y; Oikawa Y; Nakamura K
    Nihon Yakurigaku Zasshi; 1978 Mar; 74(2):251-65. PubMed ID: 207628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry.
    Jones GH; Hernandez TD; Kendall DA; Marsden CA; Robbins TW
    Pharmacol Biochem Behav; 1992 Sep; 43(1):17-35. PubMed ID: 1384071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subchronic methamphetamine treatment selectively attenuates apomorphine-induced decrease in 3,4-dihydroxyphenylacetic acid level in mesolimbic dopaminergic regions.
    Watanabe H
    Life Sci; 1985 Dec; 37(24):2319-25. PubMed ID: 4068904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
    Lin Z; Dodd CA; Filipov NM
    Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats.
    Kaneno S; Watanabe A; Takahashi R
    Eur J Pharmacol; 1986 Apr; 123(2):287-94. PubMed ID: 3086109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
    Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical and behavioral studies on the mode of action of oxypertine.
    Moroji T; Okuyama T; Hagino Y; Sekiguchi R
    Arzneimittelforschung; 1986 May; 36(5):804-8. PubMed ID: 2873819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of single and repeated application of clonazepam and diazepam combined with cyproheptadine on apomorphine stereotypy in rats.
    Georgiev VP; Petkov VV
    Agressologie; 1985 Jan; 26(1):57-60. PubMed ID: 4041139
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors.
    Fuxe K; Fredholm BB; Agnati LF; Corrodi H
    Brain Res; 1978 May; 146(2):295-311. PubMed ID: 647392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of deaminated metabolites of dopamine in noradrenaline neurons.
    Andén NE; Grabowska-Andén M
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):1-6. PubMed ID: 6633676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential responses in central dopaminergic activity induced by apomorphine in IPL nude rat.
    Estrella CR; Bregonzio C; Cabrera RJ
    Behav Brain Res; 2002 Jul; 133(2):143-8. PubMed ID: 12110447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of single and repeated application of clonazepam and diazepam independently and in combination with cyproheptadine on apomorphine stereotypy in rats.
    Georgiev VP; Petkov VV
    Acta Physiol Pharmacol Bulg; 1984; 10(3):10-5. PubMed ID: 6543287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonazepam and 5-hydroxytryptophan-induced myoclonic stereotypy.
    Weiner WJ; Goetz C; Nausieda PA; Klawans HL
    Eur J Pharmacol; 1977 Nov; 46(1):21-4. PubMed ID: 303572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and biochemical effects of a novel calcium antagonist, KB-2796, on the central dopaminergic system.
    Ozaki A; Ikegami A; Yoshidomi M; Yamashita A; Sukamoto T
    Eur J Pharmacol; 1991 Aug; 200(2-3):311-7. PubMed ID: 1782992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced stereotyped response to amphetamine after pretreatment with small doses of molindone.
    Conway P; Uretsky NJ
    Neuropharmacology; 1983 May; 22(5):579-86. PubMed ID: 6308493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the acute actions of amine-depleting drugs and dopamine receptor antagonists on dopamine function in the brain in rats.
    Hong M; Jenner P; Marsden CD
    Neuropharmacology; 1987; 26(2-3):237-45. PubMed ID: 2884588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2 receptors and dopamine metabolism. Relationship between biochemical and behavioural effects of substituted benzamide drugs.
    Magnusson O; Fowler CJ; Köhler C; Ogren SO
    Neuropharmacology; 1986 Feb; 25(2):187-97. PubMed ID: 2939362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats.
    Matthews RT; Champney TH; Frye GD
    Pharmacol Biochem Behav; 1989 Aug; 33(4):741-7. PubMed ID: 2575758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.